Addendum No. 2, dated August 14, 2020, to the Supply Contract dated July 30, 2019, between Isoray Medical, Inc., and Joint Stock Company Isotope (confidential portions of the exhibit have been omitted)

Contract Categories: Business Finance - Stock Agreements
EX-10.55 3 ex_204437.htm EXHIBIT 10.55 ex_158570.htm

Exhibit 10.55


Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.


Addendum No. 2 dated July 12, 2020 to

Contract No. 840/08625142/31/92-19

dd: 2019.07.31



Joint Stock Company «Isotope»,

(JSC «Isotope»)


Pogodinskaya str., 22, Moscow, 119435, Russia.

Phone: +7(495) 981-96-16.



The Company Isoray Medical Inc.

350 Hills Street, Suite 106

Richland, WA ###-###-#### USA


THE BUYER and THE SELLERS have mutually agreed about the following:



The total activity of shipments under the Contract on calibration date is increased on [**] and is equal to [**].

2. The total amount of the Ñontract is increased on USD [**] and is equal to USD [**].


All other terms and conditions are in accordance with Contract No. 840/08625142/31/92-19, Appendices 1 and 2, Addendum 1. The present Addendum 2 is an integral part of the Contract and may be signed via E-mail.


/s/ Anton Shargin                     /s/ Jennifer Streeter              
Anton Shargin   Jennifer Streeter  
Director of Department of Isotope Product Sales   14 Aug 2020  
JSC Isotope   Isoray - COO